ERIN HASKIN: Open Payments
NPI 1235747221 · THOMASVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$583 in 25 payments from 14 companies in 2025. Trend: 2023 $361 · 2024 $476 · 2025 $583
Food & beverage: $583
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $169 |
| Seqirus USA Inc | 3 | $58 |
| LEO Pharma Inc. | 2 | $50 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
| Lilly USA, LLC | 2 | $45 |
| PFIZER INC. | 2 | $34 |
| Dexcom, Inc. | 1 | $33 |
| AstraZeneca Pharmaceuticals LP | 1 | $29 |
| JAZZ PHARMACEUTICALS INC. | 1 | $25 |
| Medtronic, Inc. | 1 | $22 |
Products named: Ozempic, LIBTAYO, Fluad, Rybelsus, PREVNAR 20, Dexcom G6 Transmitter, KISUNLA, FASENRA.
Industry payments across GA — which companies pay providers there.
